https://www.selleckchem.com/products/jtc-801.html
The median primary access survival (mean, 1183 ± 312 days) was longer than PTAs alone (P less then .01). No major or minor complications were associated with stent-graft deployment or any of the subsequent interventions in the study period. The primary patency rate at 6, 12, and 18 months was 100%, and it was 85.7% at 24 months. The secondary access patency rate was 92.9% at 24 months. In conclusion, stent-graft placement to salvage CVS stents with recalcitrant restenosis in patients with AV fistulas is safe and effective if PTAs fails
Like
Comment
Share
